Brain Cancer

Clinical Trials

2014-0242

Title: A Randomized Phase 3 Open Label Study of Nivolumab versus Bevacizumab and a Safety Study of Nivolumab or Nivolumab in Combination with Ipilimumab in Adult Subjects with Recurrent Glioblastoma (GBM)

Description: The purpose of this study is to establish the safety, tolerability and efficacy of nivolumab and nivolumab in combination with ipilimumab versus standard of care treatment (bevacizumab) in patients diagnosed with recurrent glioblastoma. 

For more information on this study from ClinicalTrials.gov, click here!